ResMed (RMD) risk factors: FY2026 10-K

1. Our inability to compete with new and existing technology may harm our business.reworded
2. Consolidation in the healthcare industry and healthcare payment reform could have an adverse effect on our revenues and results of operations.
3. Global macroeconomic conditions, including the direct and indirect effects of inflation, supply chain disruptions, reciprocal tariffs, and fluctuations in foreign currency exchange rates, could adversely affect our operations and profitability.Tariffs

Read these in Item 1A · See the changes

1. Our business, financial condition and results of operations could be harmed by the effects of pandemics, epidemics, or other public health crises.

Read these in Item 1A · See the changes

1. We are subject to various risks relating to international activities that could affect our overall profitability.
2. Our products are the subject of clinical trials conducted by us, our competitors, or other third parties, the results of which may be unfavorable, or perceived as unfavorable, and could have a material adverse effect on our business, financial condition, and results of operations.

Read these in Item 1A · See the changes

1. We are subject to potential product liability claims that may exceed the scope and amount of our insurance coverage, which would expose us to liability for uninsured claims.
2. We are subject to potential professional services liability claims due to our recent acquisition of VirtuOx, which may exceed the scope and amount of our insurance coverage, which would expose us to liability for uninsured claims.new
3. Our intellectual property may not protect our products, and/or our products may infringe on the intellectual property rights of third parties.

Read these in Item 1A · See the changes

1. If we fail to source, develop and retain key employees, our business may suffer.
2. Our leverage and debt service obligations could adversely affect our business.
3. We are subject to new areas of direct healthcare oversight by federal government agencies due to our acquisitions of VirtuOx and Noctrix.reworded

Read these in Item 1A · See the changes

1. Disruptions in the supply of components from our suppliers could result in a significant reduction in sales and profitability.
2. We are increasingly dependent on information technology systems and infrastructure. Failed, substandard or delayed efforts to improve our IT System infrastructure may result in disruption to our business or materiallyreworded
3. RESMED INC. AND SUBSIDIARIES increased costs.new
4. Actual or attempted breaches of security, unauthorized disclosure of information, attacks which reduce availability of systems such as denial of service, or the perception that personal and/or other sensitive or confidential information in our possession is not secure, could result in a material loss of business, substantial legal liability or significant harm to our reputation.

Read these in Item 1A · See the changes

1. Failure to identify, execute, and integrate acquired businesses into our operations successfully, or challenges related to the Company's strategic initiatives, including divestitures.new
2. If we are unable to support our continued growth or achieve expected operating efficiencies, our business could suffer.

Read these in Item 1A · See the changes

1. Our business depends on our ability to effectively educate and engage dealers of home healthcare products, sleep clinics and physicians, health care providers, and patients regarding the benefits of our products, software solutions and services.new
2. The success of our software offerings depends substantially on customers entering, renewing, upgrading and expanding their agreements for cloud services, term licenses, and maintenance and support agreements with us. Any decline in our customer renewals, upgrades or expansions could adversely affect our future operating results.
3. If our software products fail to perform properly or if we fail to develop enhancements, we could lose customers, become subject to service performance or warranty claims and our sales could decline.

Read these in Item 1A · See the changes

1. If there are interruptions or performance problems associated with our technology or infrastructure, our existing software customers may experience service outages, and our new customers may experience delays in the deployment of our platforms.
2. Climate change and natural disasters, or other events beyond our control, could negatively impact our business operations and financial condition.

Read these in Item 1A · See the changes

1. Healthcare reform or other cost-cutting measures, including changes in coverage policy for our products and services, by government or commercial payors may have a material adverse effect on our industry and our results of operations.

Read these in Item 1A · See the changes

1. Government and private insurance plans may not adequately reimburse our customers for our products, which could result in reductions in sales or selling prices for our products.

Read these in Item 1A · See the changes

1. We are subject to various risks relating to our compliance with fraud and abuse laws and transparency laws relating to our interactions with our customers, healthcare providers, other referral sources and patients, which could subject us to government investigation, litigation, or other penalties to the extent our activities or relationships are found not to comply or could otherwise cause us to incur significant costs to defend our actions, and could result in substantial fines, penalties, harm our reputation in the market, divert our management’s attention, or result in changes in our business operations that could harm our ability to successfully market and sell our products and services.reworded

Read these in Item 1A · See the changes

1. Our use and disclosure of personal information, including health information, is subject to federal, state and foreign privacy, artificial intelligence, data, biometrics and security regulations, and our failure to comply with those regulations or to adequately secure the information we hold could result in significant liability, regulatory investigations, legal actions, or reputational harm.AI

Read these in Item 1A · See the changes

1. Our use of artificial intelligence in certain products, software solutions and business operations may expose us to operational, regulatory and reputational risks that could adversely affect our business, financial condition and results of operations.newAI
2. Product sales, introductions or modifications may be delayed or canceled as a result of FDA regulations or similar foreign regulations, which could cause our sales and profits to decline.

Read these in Item 1A · See the changes

1. We are subject to substantial regulation related to quality standards applicable to our manufacturing and quality processes. Our failure to comply with these standards could have an adverse effect on our business, financial condition, or results of operations.
2. Disruptions at the FDA and other government agencies caused by funding shortages, personnel reductions, or global health concerns could hinder their ability to hire, retain or deploy key leadership and other personnel, or otherwise prevent new or modified products from being developed, cleared or approved or commercialized in a timely manner or at all, which could negatively impact our business.

Read these in Item 1A · See the changes

1. Off-label marketing of our products could result in substantial penalties.
2. Laws regulating consumer contacts could adversely affect our business operations or create liabilities.
3. Income tax laws, regulations, and enforcement practices in various jurisdictions are evolving and, as a result, tax authorities are aggressively pursuing taxpayers. This may result in expense as well as management distraction, which may result in a material adverse effect on our results of operations, cash flows and financial position.reworded

Read these in Item 1A · See the changes

1. We are subject to ongoing tax audits by various local tax authorities, some of which are aggressively pursuing taxes on transferred or discontinued local operations.reworded
2. Sustainability and corporate governance issues are constantly evolving, leading to additional investment and expense, and may have an adverse effect on our business, financial condition and results of operations and reputation.

Read these in Item 1A · See the changes

1. Our quarterly operating results are subject to fluctuation for a variety of reasons.
2. Our ability to sustain or grow dividends or repurchase shares is subject to board discretion.
3. Delaware law and provisions in our charter could make it difficult for another company to acquire us.

Read these in Item 1A · See the changes

Headings in the FY2025 10-K with no match this year.

1. We may not be able to realize the anticipated benefits from acquisitions, which could adversely affect our operating results.
2. Our business depends on our ability to market effectively to dealers of home healthcare products, sleep clinics, and physicians.